abstract |
The present invention relates to (5)-2-((2-((5)-4-(difluoromethyl)-2-oxooxazolidine-3-yl)-5,6- Dihydrobenzo[f]imidazo[1,2‑J][1,4]oxazepine -9-yl)amino)propionamide (GDC-0077) (or its stereoisomers, geometric isomers, tautomers and pharmaceutically acceptable salts) in the form of crystalline polymorphs, and the preparation of said polymorphs method of crystalline form, |